 |
Alendronate disodium |
|---|---|
| Trade Name | Fosamax |
| Orphan Indication | Gaucher disease |
| USA Market Approval | USA |
| USA Designation Date | 2001-02-13 00:00:00 |
| Sponsor | Richard J. Wenstrup, M.D.;Division of Human Genetics, Children's Hospital Research Foundation;Cincinnati, Ohio, 45229 |
